Triamcinolone Injectable (Im, Intra-Articular) Suppliers & Bulk Manufacturers
Available Forms: Injectable (IM, intra-articular)
Available Strengths: 40 mg/mL, 80 mg/mL, 80 mg/2 mL
Reference Brands: Kenalog(US & EU)
Category:
Arthritis
Triamcinolone injectable inhibits inflammation by suppressing cytokine production, decreasing immune activity, and reducing tissue swelling. It provides rapid relief in joint flare-ups, arthritis, and allergic conditions. Benefits include targeted, long-lasting anti-inflammatory effects, improved joint function, and minimized systemic side effects when used appropriately, making it effective for acute and chronic inflammatory management.
Triamcinolone Injectable (IM, intra-articular) is available in Injectable (IM, intra-articular)
and strengths such as 40 mg/mL, 80 mg/mL, 80 mg/2 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Triamcinolone Injectable (IM, intra-articular) is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Triamcinolone Injectable (IM, intra-articular) can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Triamcinolone injectable (IM and intra-articular) is approved in the EU and US for managing inflammatory and autoimmune conditions, including rheumatoid arthritis. In the EU, brands like Kenalog are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on comprehensive clinical data, biosimilarity assessments, and pharmacovigilance. Both regions require detailed dossiers for initial approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market access for triamcinolone injectable formulations, ensuring adherence to European and US standards for safe, effective anti-inflammatory therapy and seamless navigation of complex regulatory landscapes.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing